What is the procedure for preparing platelet-rich plasma (PRP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Platelet-Rich Plasma (PRP) Preparation Procedure

The standard procedure for preparing platelet-rich plasma (PRP) involves collecting anticoagulated blood, centrifugation at specific speeds, separation of components, and optional activation before clinical application. 1

Blood Collection and Anticoagulation

  • Collect autologous blood at the time of therapeutic application in a laboratory, operating theater, or clinic room 1
  • Use appropriate anticoagulants:
    • Trisodium citrate is most widely used with few negative effects on PRP preparation 1
    • Acid citrate dextrose (ACD) and citrate phosphate dextrose (CPD), including those with adenine (ACD-A, CPD-A) are effective alternatives 1
    • AVOID EDTA as it causes platelet swelling and activation 1
  • For research purposes, blood samples should be collected in EDTA-coated tubes for quality control measurements to maintain stable platelet counts for up to 24 hours 2

Centrifugation Process

Traditional Single-Step Method

  • Centrifuge anticoagulated blood at low force (170-200 g) for 10 minutes at room temperature 1
  • This provides a relatively pure preparation with good PRP yield 1

Optimized Two-Step Method

  • First spin: 100 g for 10 minutes (promotes high platelet recovery) 3
  • Second spin: 400 g for 10 minutes 3
  • Withdraw 2/3 of remnant plasma to achieve high platelet recovery (70-80%) and concentration (5x) while maintaining platelet integrity and viability 3
  • Process smaller blood volumes (3.5 mL) for better platelet recovery compared to larger volumes (8.5 mL) 3

Main Clinical Preparation Methods

Three main methods are available for sterile PRP product preparation 1:

  1. Gravitational centrifugation techniques:

    • Most common and accessible method
    • Uses varying g-force and centrifugation times that affect yield, concentration, purity, viability, and activation status 1
  2. Standard cell separators:

    • Operate on a full unit of blood
    • Use continuous-flow centrifuge bowl or disk separation technology
    • Combine hard and soft centrifugation steps
    • High g-force centrifugation isolates the buffy coat layer containing platelets and leukocytes 1
  3. Autologous selective filtration technology (plateletpheresis):

    • Specialized filtration method for platelet concentration 1

PRP Activation

  • PRP must be activated for platelets to release their α-granule contents 1
  • The resulting clot provides a scaffold to capture secreted proteins and maintain their presence at the application site 1
  • Activation methods include:
    • Thrombin
    • Re-calcification
    • Contact with collagen-rich tissues (in some applications) 1
  • Consider whether activation should be performed prior to or at the time of clinical application 1

PRP Classification and Quality Control

  • PRP preparations vary widely in content, purity, and biological properties, affecting clinical efficacy 1
  • The International Society on Thrombosis and Haemostasis (ISTH) proposed a classification system based on:
    • Leukocyte content (≥1%)
    • Red blood cell content (≥10%)
    • Activation method
    • Platelet concentration
    • Preparation technique 1
  • For quality control, samples should be taken in EDTA-coated tubes and analyzed using validated cell counters 2

Important Considerations and Pitfalls

  • PRP should be used within 6 hours after preparation (though stability remains uncertain) 1
  • Different centrifugation protocols significantly impact platelet yield, concentration, and viability 3
  • Commercial PRP preparation devices result in significant variation in product content 1
  • The presence of leukocytes may impact biological properties through immune and antibacterial effects and influence tissue healing 1
  • Lack of standardization in preparation methods contributes to variable clinical outcomes 4
  • Processing larger blood volumes may reduce platelet recovery efficiency 3

Emerging Techniques

  • Newer ultrafiltration technologies incorporate platelet-poor plasma (PPP) processing to create protein-rich PRP (PR-PRP) matrices 5
  • These techniques concentrate not only platelets but also functional plasma proteins like fibrinogen, albumin, and alpha-2-macroglobulin 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.